Effects of Chronic Kidney Disease on Cognitive Function and α-klotho Expression in Hippocampus

Overview

Journal Transl Androl Urol

Date 2022 Sep 12

PMID 36092842

Authors

Menglan Huang

Guangzhi Li

Junhua Tan

Meiying Huang

Feifan Huang

Ruiying Ma

Yu Xiao

Jie Wang

Affiliations

Soon will be listed here.

Abstract

Background: Alpha-klotho (α-KL) is not only related to the regulation of calcium-phosphorus metabolism, and fibrosis in chronic kidney disease (CKD), it is also involved in the regulation of many cognitive disorders. We conducted this study to investigate the effects of CKD on cognitive dysfunction and α-KL.

Methods: Doxorubicin was used to induce a CKD model, which was validated by weight, 24-hour urine protein quantification, serum creatinine (Cr), blood urea nitrogen (BUN), and kidney hematoxylin-eosin (HE) staining. The Morris water maze (MWM) paradigm was used to assess the effects of CKD on cognitive behavior. The expression of α-KL in the hippocampus was detected using real-time quantitative polymerase chain reaction, Western blot, and immunohistochemistry (IHC).

Results: (I) In the CKD group, the weight of the rats increased slowly (P<0.001), 24-hour urine protein increased (P<0.05), and Cr (P=0.026) and BUN levels (P=0.003) increased; (II) HE staining showed that in the CKD group there were changes in the structure, fibrosis, and inflammatory infiltration of the renal tissues, and changes in the structure, cell necrosis, and neuronal degeneration of the hippocampus; (III) in the MWM experiment, the escape latency of the CKD group was prolonged compared to that of the control group (P=0.043, 0.023), and the number of crossing the platform was reduced (P=0.003); (IV) in the CKD group, the expressions of α-KL messenger ribonucleic acid (P=0.0005) and α-KL protein (P=0.0005) in the hippocampus were downregulated. The IHC results showed that the expression of α-KL protein in the hippocampal region III cornus ammonis (CA3) of the CKD group region was also downregulated, and the α-KL-positive cells (P=0.019) and mean optical density (P=0.015) were decreased.

Conclusions: The expression of α-KL appears to effect the cognitive function of CKD rats; thus, it may be a valuable target in the treatment of CKD with cognitive impairment.

Citing Articles

Relationships between serum Klotho concentrations and cognitive performance among older chronic kidney disease patients with albuminuria in NHANES 2011-2014.

Zhang J, Zhang A Front Endocrinol (Lausanne). 2023; 14:1215977.

PMID: 37560310 PMC: 10407554. DOI: 10.3389/fendo.2023.1215977.

References

Zhao Y, Zeng C, Li X, Yang T, Kuang X, Du J . Klotho overexpression improves amyloid-β clearance and cognition in the APP/PS1 mouse model of Alzheimer's disease. Aging Cell. 2020; :e13239. PMC: 7576297. DOI: 10.1111/acel.13239. View

Cherubini E, Miles R . The CA3 region of the hippocampus: how is it? What is it for? How does it do it?. Front Cell Neurosci. 2015; 9:19. PMC: 4318343. DOI: 10.3389/fncel.2015.00019. View

Li-Zhen L, Chen Z, Wang S, Liu W, Zhuang X . Klotho deficiency causes cardiac ageing by impairing autophagic and activating apoptotic activity. Eur J Pharmacol. 2021; 911:174559. DOI: 10.1016/j.ejphar.2021.174559. View

Chen H, Huang X, Fu C, Wu X, Peng Y, Lin X . Recombinant Klotho Protects Human Periodontal Ligament Stem Cells by Regulating Mitochondrial Function and the Antioxidant System during HO-Induced Oxidative Stress. Oxid Med Cell Longev. 2019; 2019:9261565. PMC: 6914990. DOI: 10.1155/2019/9261565. View

Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A . Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016; 4(5):e307-19. DOI: 10.1016/S2214-109X(16)00071-1. View

Sedighi M, Baluchnejadmojarad T, Fallah S, Moradi N, Afshin-Majdd S, Roghani M . Klotho Ameliorates Cellular Inflammation via Suppression of Cytokine Release and Upregulation of miR-29a in the PBMCs of Diagnosed Alzheimer's Disease Patients. J Mol Neurosci. 2019; 69(1):157-165. DOI: 10.1007/s12031-019-01345-5. View

Yuan Q, Ren Q, Li L, Tan H, Lu M, Tian Y . A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling. Nat Commun. 2022; 13(1):438. PMC: 8782923. DOI: 10.1038/s41467-022-28096-z. View

Sedighi M, Baluchnejadmojarad T, Afshin-Majd S, Amiri M, Aminzade M, Roghani M . Anti-aging Klotho Protects SH-SY5Y Cells Against Amyloid β1-42 Neurotoxicity: Involvement of Wnt1/pCREB/Nrf2/HO-1 Signaling. J Mol Neurosci. 2020; 71(1):19-27. DOI: 10.1007/s12031-020-01621-9. View

Lee J, Tsogbadrakh B, Yang S, Ryu H, Kang E, Kang M . Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1α-mediated renal mitochondrial protection. Biochem Biophys Res Commun. 2020; 534:1040-1046. DOI: 10.1016/j.bbrc.2020.10.040. View

10.

Floege J, Fliser D . Klotho Deficiency and the Cardiomyopathy of Advanced CKD. J Am Soc Nephrol. 2014; 26(6):1229-31. PMC: 4446885. DOI: 10.1681/ASN.2014090951. View

11.

Moreno J, Izquierdo M, Sanchez-Nino M, Suarez-Alvarez B, Lopez-Larrea C, Jakubowski A . The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB. J Am Soc Nephrol. 2011; 22(7):1315-25. PMC: 3137579. DOI: 10.1681/ASN.2010101073. View

12.

Wang Y, Wang K, Bao Y, Zhang T, Ainiwaer D, Xiong X . The serum soluble Klotho alleviates cardiac aging and regulates M2a/M2c macrophage polarization via inhibiting TLR4/Myd88/NF-κB pathway. Tissue Cell. 2022; 76:101812. DOI: 10.1016/j.tice.2022.101812. View

13.

Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T . Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390(6655):45-51. DOI: 10.1038/36285. View

14.

Xue M, Yang F, Le Y, Yang Y, Wang B, Jia Y . Klotho protects against diabetic kidney disease via AMPK- and ERK-mediated autophagy. Acta Diabetol. 2021; 58(10):1413-1423. DOI: 10.1007/s00592-021-01736-4. View

15.

Xiang T, Luo X, Zeng C, Li S, Ma M, Wu Y . Klotho ameliorated cognitive deficits in a temporal lobe epilepsy rat model by inhibiting ferroptosis. Brain Res. 2021; 1772:147668. DOI: 10.1016/j.brainres.2021.147668. View

16.

Lee J, Ju K, Kim H, Tsogbadrakh B, Ryu H, Kang E . Soluble α-klotho anchors TRPV5 to the distal tubular cell membrane independent of FGFR1 by binding TRPV5 and galectin-1 simultaneously. Am J Physiol Renal Physiol. 2021; 320(4):F559-F568. DOI: 10.1152/ajprenal.00044.2021. View

17.

Milovanova L, Taranova M, Milovanova S, Kozlovskaya Lysenko L, Pasechnik A, Kozlov V . Cardiovascular remodeling as a result of fibroblast growth factor-23 (FGF-23)/Klotho imbalance in patients with CKD. Int Urol Nephrol. 2021; 54(7):1613-1621. DOI: 10.1007/s11255-021-03046-8. View

18.

Bertani T, CUTILLO F, Zoja C, Broggini M, Remuzzi G . Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int. 1986; 30(4):488-96. DOI: 10.1038/ki.1986.212. View

19.

Li T, Xie Y, Bowe B, Xian H, Al-Aly Z . Serum phosphorus levels and risk of incident dementia. PLoS One. 2017; 12(2):e0171377. PMC: 5289565. DOI: 10.1371/journal.pone.0171377. View

20.

Kuro-O M . The Klotho proteins in health and disease. Nat Rev Nephrol. 2018; 15(1):27-44. DOI: 10.1038/s41581-018-0078-3. View